Compared with adjacent tissues, REV1, Rad18, RPA32 and REV7 showed higher expression in lung cancer tissues (Supplementary Fig. 1), indicating that TLS may be abnormally activated in lung cancer. The gene discussed is RAD18; the disease is lung carcinoma.